Ming‐Ju Hsieh
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms 15
- Molecular Biology top 5%
- Cell death mechanisms and regulation 10
- Phytochemical compounds biological activities 10
- Cancer-related gene regulation 10
- Natural product bioactivities and synthesis 9
- Pharmacology top 2%
-
- Peptidase Inhibition and Analysis 11
-
- Autophagy in Disease and Therapy 11
-
- Cancer Mechanisms and Therapy 8
Ming‐Ju Hsieh
137 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 116
- Cancer Research 689
- Complementary and alternative medicine 247
- Molecular Biology 1.9k
- Pharmacology 231
- Endocrine and Autonomic Systems 160
Countries citing papers authored by Ming‐Ju Hsieh
This map shows the geographic impact of Ming‐Ju Hsieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Ju Hsieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Ju Hsieh more than expected).
Fields of papers citing papers by Ming‐Ju Hsieh
This network shows the impact of papers produced by Ming‐Ju Hsieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Ju Hsieh. The network helps show where Ming‐Ju Hsieh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming‐Ju Hsieh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 8 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 3 | |
| 11 | 2021 | 16 | |
| 12 | 2020 | 22 | |
| 13 | 2019 | 6 | |
| 14 | 2017 | 52 | |
| 15 | 2017 | 12 | |
| 16 | 2016 | 9 | |
| 17 | 2015 | 17 | |
| 18 | 2015 | 16 | |
| 19 | 2015 | 55 | |
| 20 | 2012 | 40 |
About Ming‐Ju Hsieh
Ming‐Ju Hsieh is a scholar working on Applied Microbiology and Biotechnology, Cancer Research and Molecular Biology, having authored 140 papers that have together received 3.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (15 papers), Peptidase Inhibition and Analysis (11 papers), Autophagy in Disease and Therapy (11 papers), Cell death mechanisms and regulation (10 papers), Phytochemical compounds biological activities (10 papers), Cancer-related gene regulation (10 papers), Natural product bioactivities and synthesis (9 papers) and Cancer Mechanisms and Therapy (8 papers). The work is most often cited by research in Cancer Research (689 citations), Complementary and alternative medicine (247 citations) and Molecular Biology (1.9k citations). Ming‐Ju Hsieh has collaborated with scholars based in Taiwan, United States and Vietnam. Frequent co-authors include Shun‐Fa Yang, Mu‐Kuan Chen, Chiao‐Wen Lin, Hui‐Ling Chiou, Yu‐Sheng Lo, Yi‐Ching Chuang, Wei‐En Yang, Chia‐Chieh Lin, Yih‐Shou Hsieh and Ying‐Erh Chou. Their work appears in journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.